===============================================================================
/------------------------------/
/ OMB APPROVAL /
/------------------------------/
/ OMB Number: 3235-0287 /
/ Expires: January 31, 2005 /
/ Estimated average burden /
/ hours per response...... 0.5 /
/------------------------------/
+--------+
| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION
+--------+ Washington, D.C. 20549
[_] Check this box if
no longer subject STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
to Section 16.
Form 4 or Form 5 Filed pursuant to Section 16(a) of the Securities
obligations may Exchange Act of 1934, Section 17(a) of the
continue. See Public Utility Holding Company Act of 1935 or
Instruction 1(b). Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Lai-Goldman, Myla P.
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Laboratory Corporation of America
420 South Spring Street
- --------------------------------------------------------------------------------
(Street)
Burlington North Carolina 27215
- --------------------------------------------------------------------------------
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Labortory Corporation of America Holdings ("LH")
----------------------------------------------------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity
(voluntary)
--------------
4. Statement for Month/Year February 2002
--------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
---------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
___ Director X Officer ___ 10% Owner ___ Other
--- (give title below) (specify below)
Executive Vice President, Chief Scientific Officer and Medical Director
- --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
---
____ Form filed by More than One Reporting Person
- -------------------------------------------------------------------------------
Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- --------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature of
of action action or Disposed of (D) Securities ship Indirect
Security Date Code (Instr. 3, 4 and 5) Beneficially Form: Benefically
(Instr. 3) (Month/ (Instr. 8) Owned at Direct Ownership
Day/ ------------------------------------------- End of (D) or
Year) Month Indirect
Code V Amount (A)or (D) Price (Instr. 3 and 4) (I)
(Instr. 4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 02/27/02 M 14,800 A $20.625 D
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 02/27/02 S 4,800 D $81.9992 D
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 02/27/02 S 10,000 D $81.95 80,253.1787 D
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Conversion 3. Transaction 4. Transaction 5. Number of
Security (Instr. 3) or Exercise Date Code Derivative Securities
Price of (Month/Day/ (Instr. 8) Acquired (A) or
Derivative Year) Disposed of (D)
Security (Instr. 3, 4, and 5)
--------------------------------------------------
Code V (A) (D)
- -----------------------------------------------------------------------------------------------------------------------------
Employee
Stock Option(1) $20.625 02/27/02 M 14,800
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
6. Date Exer- 7. Title and Amount of 8. Price 9. Number 10. Owner- 11. Nature
cisable and Underlying Securities of of Deriv- ship of In-
Expiration (Instr. 3 and 4) Deriv- ative Form direct
Date ative Securities of De- Bene-
(Month/Day/ Security Beneficially rivative ficial
Year) (Instr. Owned at End Securities Owner-
5) of Month Bene- ship
(Instr. 4) ficially (Instr.
Owned at 4)
End of
Month
(Instr. 4)
--------------------------------------------
Date Amount or
Exer- Expiration Number of
cisable Date Title Shares
- --------------------------------------------------------------------------------------------------------------------------------
Common
(2) 02/09/10 Stock 14,800 7,400 D
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
(1) Common stock purchase option granted pursuant to Laboratory Corporation of
America Holdings 1994 Stock Option Plan.
(2) Total option to purchase 22,200 shares vests in three equal installments on
February 9, 2001, February 9, 2002, and February 9, 2003.
/s/ Bradford T. Smith March 11, 2002
--------------------------------------- ----------------
**Signature of Reporting Person Date
Bradford T. Smith, Attorney-In-Fact for
Myla P. Lai-Goldman
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If this form is filed by more than one reporting person, see
Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
